Sanofi-led group buys Globalpharma stake from Dubai Investments
Reuters
Published Jun 26, 2014 11:12
DUBAI (Reuters) - French drugmaker Sanofi (PA:SASY) is leading an investor group buying a 66 percent stake in the Globalpharma unit of Dubai Investments
Under the agreement, Globalpharma will be managed as a Sanofi company and will become the platform to manufacture and promote its generic drugs portfolio in the Middle East.
No purchase price was given in the bourse filing in Dubai, but Dubai Investments - which will retain the remaining 34 percent of the firm - said the deal had generated an internal rate of return of 26 percent over a ten-year period.
"We believe that the new partnership being forged with Sanofi will propel Globalpharma to the next level of its growth," said Khalid bin Kalban, chief executive of Dubai Investments.
Kalban added the penetration of generic drug manufacturing had traditionally been low in the Middle East but was now gradually increasing towards European levels, while the wider pharmaceutical sector was expected to experience strong growth in coming years due to favourable demographics and higher per capita income.
Globalpharma manufactures pharmaceutical products including antibiotics, painkillers, cardiovascular drugs and food supplements and is registered in more than 14 countries across the Middle East and neighbouring markets, the statement said.
News of the divestment helped Dubai Investments' share price recover ground lost earlier in the session, though it was still 2 percent lower at 0925 GMT against a wider market <.DFMGI> decline of 0.4 percent. Sanofi was trading flat.
(Reporting by David French; Editing by Andrew Torchia and Mark Potter)
Get The App
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.